Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) (SCIGG-134)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD89 and anti-malaria antigen IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD89 & malaria antigen

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD89

Gene ID

2204

UniProt ID

P24071

Alternative Names

FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD89 & malaria antigen"

See other bsAb targets related to "CD89"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) (SCIGG-134). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (scIgG) (CAT#: SCIGG-134)

Specifications

Targets

Customer Reviews and Q&As